ADVIL MULTI-SYMPTOM COLD & FLU
Peakchlorpheniramine maleate, ibuprofen, and phenylephrine hydrochloride
NDAORALTABLET
Approved
Dec 2011
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
ADVIL MULTI-SYMPTOM COLD & FLU (chlorpheniramine maleate, ibuprofen, and phenylephrine hydrochloride) by GSK is cyclooxygenase inhibitors [moa]. First approved in 2011.
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ADVIL MULTI-SYMPTOM COLD & FLU is a fixed-dose oral combination tablet containing ibuprofen (NSAID), chlorpheniramine maleate (antihistamine), and phenylephrine hydrochloride (decongestant). It works primarily through cyclooxygenase inhibition to reduce inflammation and pain while addressing multiple cold and flu symptoms simultaneously. This product targets consumers seeking broad symptomatic relief from upper respiratory infections.
Peak
Peak lifecycle stage indicates stable, mature market position with established sales infrastructure; brand team size likely optimized for profitability rather than growth investment.
Mechanism of Action
Cyclooxygenase Inhibitors
Pharmacologic Class:
Nonsteroidal Anti-inflammatory Drug
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ADVIL MULTI-SYMPTOM COLD & FLU offers stable, operationally focused career roles in a mature OTC brand with established market presence and limited growth expectations. Career advancement is primarily through excellence in execution, retail partnerships, and operational efficiency rather than innovation or clinical development.
Brand Manager
Worked on ADVIL MULTI-SYMPTOM COLD & FLU at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.